{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:18:13Z","timestamp":1771870693945,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00277-015-2475-z","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T02:48:01Z","timestamp":1439779681000},"page":"1859-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia\/lymphoma"],"prefix":"10.1007","volume":"94","author":[{"given":"Amandine","family":"Segot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Raffoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Lengline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cluzeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"issue":"10","key":"2475_CR1","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104(10):3009\u20133020. doi: 10.1182\/blood-2004-02-0405","journal-title":"Blood"},{"issue":"24","key":"2475_CR2","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79(24):7824\u20137827","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2475_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00277-010-1104-0","volume":"90","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C (2011) Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma. Ann Hematol 90(5):539\u2013546. doi: 10.1007\/s00277-010-1104-0","journal-title":"Ann Hematol"},{"issue":"3","key":"2475_CR4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","volume":"85","author":"C Soussain","year":"1995","unstructured":"Soussain C, Patte C, Ostronoff M, Delmer A, Rigal-Huguet F, Cambier N, Leprise PY, Francois S, Cony-Makhoul P, Harousseau JL et al (1995) Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85(3):664\u2013674","journal-title":"Blood"},{"issue":"2","key":"2475_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pbc.21794","volume":"52","author":"MJ Burke","year":"2009","unstructured":"Burke MJ, Dayton V (2009) Treatment of a CNS relapse while on therapy for Burkitt lymphoma. Pediatr Blood Cancer 52(2):290\u2013292. doi: 10.1002\/pbc.21794","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2475_CR6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3324\/haematol.2014.123273","volume":"100","author":"R Bassan","year":"2015","unstructured":"Bassan R, Masciulli A, Intermesoli T, Audisio E, Rossi G, Pogliani EM, Cassibba V, Mattei D, Romani C, Cortelezzi A, Corti C, Scattolin AM, Spinelli O, Tosi M, Parolini M, Marmont F, Borlenghi E, Fumagalli M, Cortelazzo S, Gallamini A, Marfisi RM, Oldani E, Rambaldi A (2015) Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia. Haematologica 100(6):786\u2013793. doi: 10.3324\/haematol.2014.123273","journal-title":"Haematologica"},{"issue":"8","key":"2475_CR7","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3109\/10428194.2013.853765","volume":"55","author":"A Valentin","year":"2014","unstructured":"Valentin A, Troppan K, Pfeilstocker M, Nosslinger T, Linkesch W, Neumeister P (2014) Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia. Leuk Lymphoma 55(8):1739\u20131742. doi: 10.3109\/10428194.2013.853765","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2475_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1345\/aph.19347","volume":"34","author":"DJ Murry","year":"2000","unstructured":"Murry DJ, Blaney SM (2000) Clinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother 34(10):1173\u20131178","journal-title":"Ann Pharmacother"},{"issue":"21","key":"2475_CR9","first-page":"685","volume":"120","author":"V Ribrag","year":"2012","unstructured":"Ribrag V (2012) Addition of rituximab improves outcome of HIV negative patients with Burkitt lymphoma treated with the Lmba Protocol: results of the randomized intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882). ASH Annual Meeting Abstracts 120(21):685","journal-title":"ASH Annual Meeting Abstracts"},{"issue":"4 Suppl 2","key":"2475_CR10","first-page":"S2","volume":"36","author":"CH Pui","year":"2009","unstructured":"Pui CH, Thiel E (2009) Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol 36(4 Suppl 2):S2\u2013S16. doi: 10.1053\/j.seminoncol.2009.05.002","journal-title":"Semin Oncol"},{"issue":"12","key":"2475_CR11","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/annonc\/mdt414","volume":"24","author":"AM Evens","year":"2013","unstructured":"Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N, Jovanovic B, Barr PM, Caimi PF, Gregory SA, Gordon LI (2013) A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M\/IVAC regimen for untreated Burkitt\u2019s lymphoma. Ann Oncol 24(12):3076\u20133081. doi: 10.1093\/annonc\/mdt414","journal-title":"Ann Oncol"},{"issue":"2","key":"2475_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0360-3016(01)01639-X","volume":"51","author":"M Reni","year":"2001","unstructured":"Reni M, Ferreri AJ, Guha-Thakurta N, Blay JY, Dell\u2019Oro S, Biron P, Hochberg FH (2001) Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. Int J Radiat Oncol Biol Phys 51(2):419\u2013425","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2475_CR13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/cncr.24922","volume":"116","author":"M Spina","year":"2010","unstructured":"Spina M, Chimienti E, Martellotta F, Vaccher E, Berretta M, Zanet E, Lleshi A, Canzonieri V, Bulian P, Tirelli U (2010) Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer 116(6):1495\u20131501. doi: 10.1002\/cncr.24922","journal-title":"Cancer"},{"issue":"4","key":"2475_CR14","first-page":"187","volume":"70","author":"B Kumiega","year":"2013","unstructured":"Kumiega B, Jurczak W, Fornagiel S, Dzietczenia J, Skotnicki AB (2013) Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas. Przegl Lek 70(4):187\u2013190","journal-title":"Przegl Lek"},{"issue":"4","key":"2475_CR15","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10637-011-9632-6","volume":"30","author":"A Brion","year":"2012","unstructured":"Brion A, Legrand F, Larosa F, Schillinger F, Garnache-Ottou F, Helias P, Fontan J, Heczko M, Delaby P, Daguindau E, Vuillier J, Chauchet A, Deconinck E (2012) Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution. Invest New Drugs 30(4):1697\u20131702. doi: 10.1007\/s10637-011-9632-6","journal-title":"Invest New Drugs"},{"issue":"2","key":"2475_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14656566.9.2.301","volume":"9","author":"M Benesch","year":"2008","unstructured":"Benesch M, Urban C (2008) Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments. Expert Opin Pharmacother 9(2):301\u2013309. doi: 10.1517\/14656566.9.2.301","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"2475_CR17","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2006-08-043646","volume":"109","author":"E Jabbour","year":"2007","unstructured":"Jabbour E, O\u2019Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, Cabanillas M, Thomas DA (2007) Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood 109(8):3214\u20133218. doi: 10.1182\/blood-2006-08-043646","journal-title":"Blood"},{"issue":"9","key":"2475_CR18","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/cncr.24204","volume":"115","author":"JA Garcia-Marco","year":"2009","unstructured":"Garcia-Marco JA, Panizo C, Garcia ES, Deben G, Alvarez-Larran A, Barca EG, Sancho JM, Penarrubia MJ, Garcia-Cerecedo T, Garcia Vela JA (2009) Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma. Cancer 115(9):1892\u20131898. doi: 10.1002\/cncr.24204","journal-title":"Cancer"},{"issue":"2","key":"2475_CR19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3324\/haematol.2010.028092","volume":"96","author":"N Gokbuget","year":"2011","unstructured":"Gokbuget N, Hartog CM, Bassan R, Derigs HG, Dombret H, Greil R, Hernandez-Rivas JM, Huguet F, Intermesoli T, Jourdan E, Junghanss C, Leimer L, Moreno MJ, Reichle A, Ribera J, Schmid M, Serve H, Stelljes M, Stuhlmann R, Hoelzer D (2011) Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma. Haematologica 96(2):238\u2013244. doi: 10.3324\/haematol.2010.028092","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2475-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2475-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T07:21:57Z","timestamp":1599463317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2475-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["2475"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2475-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]}}}